Retraction: HealthLINE: A messaging chatbot for supporting chronic disease self-management

• September 7, 2026

Correction: Comparative efficacy and safety of seven Chinese patent medicines combined with SSRIs for depressive disorder: a systematic review and network meta-analysis

• by Hongye Geng, Lixuan Li, Chengyuan Lu, Shuling Wang

• September 4, 2026

Prevalence, role impairment, and mental health service utilization of depressive disorders among community-dwelling older adults in China

• by Dandan Wang, Xiaofei Hou, Zhaorui Liu, Yueqin Huang, Shuiyuan Xiao, Lingjiang Li, Tingting Zhang, Jie Yan, Yaqin Yu, Xiufeng Xu, Zhizhong Wang, Yifeng Xu, Tao Li, Xiangdong Xu, Limin Wang, Yongping Yan, Minghui Li, Guangming Xu, Huifang Yin

• September 3, 2026

FDA approves first therapy for Alexander disease

The antisense oligonucleotide reduces production of the abnormal protein that accumulates in supportive cells in the brain.

• by Kathryn Wighton

• September 4, 2026

• 2 min